BioVaxys
Phase 2BioVaxys Technology Corp, a leader in biopharmaceutical innovation focused on antiviral and cancer vaccine development. Leveraging our recent acquisition of IMV INC's IP, we're at the forefront of advancing DPX™ delivery technology and haptenized protein vaccines, targeting solid tumors and various viral infections.
Founded
2019
Focus
Biologics
About
BioVaxys Technology Corp, a leader in biopharmaceutical innovation focused on antiviral and cancer vaccine development. Leveraging our recent acquisition of IMV INC's IP, we're at the forefront of advancing DPX™ delivery technology and haptenized protein vaccines, targeting solid tumors and various viral infections.
Funding History
2Total raised: $12.5M
Series A$10MUndisclosedMar 15, 2022
Seed$2.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2019
LocationVancouver, United States
StagePhase 2
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile